Stock Information
Viridian Therapeutics Inc (VRDN)
Ticker Symbol: VRDN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,804.09 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.9999
Revenue (TTM): $0.75 M
Dividend Yield: N/A%
ROE: -58.44%
Latest News
-
RBC Capital Maintains Outperform on Viridian Therapeutics, Lowers Price Target to $42
Fri, Feb 27, 2026 2:15 PM
-
Viridian Therapeutics shares are trading lower after the company reported worse-than-expected Q4 EPS results.
Thu, Feb 26, 2026 10:15 AM
-
Earnings Breakdown: Viridian Therapeutics Q4
Thu, Feb 26, 2026 8:24 AM
-
Viridian Therapeutics Q4 EPS $(1.08) Misses $(0.93) Estimate, Sales $132.000K
Thu, Feb 26, 2026 8:23 AM
Key Financials
Financial data not available
